Skip to main content

Advertisement

Log in

HLA-G in organ transplantation: towards clinical applications

  • Multi-Author Review
  • Published:
Cellular and Molecular Life Sciences Aims and scope Submit manuscript

An Erratum to this article was published on 06 January 2011

Abstract

HLA-G plays a particular role during pregnancy in which its expression at the feto–maternal barrier participates into the tolerance of the allogenic foetus. HLA-G has also been demonstrated to be expressed in some transplanted patients, suggesting that it regulates the allogenic response. In vitro data indicate that HLA-G modulates NK cells, T cells, and DC maturation through its interactions with various inhibitory receptors. In this paper, we will review the data reporting the HLA-G involvement of HLA-G in human organ transplantation, then factors that can modulate HLA-G, and finally the use of HLA-G as a therapeutic tool in organ transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fuzzi B et al (2002) HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol 32:311–315

    Article  CAS  PubMed  Google Scholar 

  2. Jurisicova A, Casper RF, MacLusky NJ, Mills GB, Librach CL (1996) HLA-G expression during preimplantation human embryo development. Proc Natl Acad Sci USA 93:161–165

    Article  CAS  PubMed  Google Scholar 

  3. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R (1990) A class I antigen, HLA-G, expressed in human trophoblasts. Science 248:220–223

    Article  CAS  PubMed  Google Scholar 

  4. Yie SM, Xiao R, Librach CL (2006) Progesterone regulates HLA-G gene expression through a novel progesterone response element. Hum Reprod 21:2538–2544

    Article  CAS  PubMed  Google Scholar 

  5. Houlihan JM, Biro PA, Harper HM, Jenkinson HJ, Holmes CH (1995) The human amnion is a site of MHC class Ib expression: evidence for the expression of HLA-E and HLA-G. J Immunol 154:5665–5674

    CAS  PubMed  Google Scholar 

  6. Hammer A, Hutter H, Blaschitz A, Mahnert W, Hartmann M, Uchanska-Ziegler B, Ziegler A, Dohr G (1997) Amnion epithelial cells, in contrast to trophoblast cells, express all classical HLA class I molecules together with HLA-G. Am J Reprod Immunol 37:161–171

    CAS  PubMed  Google Scholar 

  7. Menier C, Rabreau M, Challier JC, Le Discorde M, Carosella ED, Rouas-Freiss N (2004) Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis. Blood 104:3153–3160

    Article  CAS  PubMed  Google Scholar 

  8. Blaschitz A, Lenfant F, Mallet V, Hartmann M, Bensussan A, Geraghty DE, Le Bouteiller P, Dohr G (1997) Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G. Eur J Immunol 27:3380–3388

    Article  CAS  PubMed  Google Scholar 

  9. Crisa L, McMaster MT, Ishii JK, Fisher SJ, Salomon DR (1997) Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. J Exp Med 186:289–298

    Article  CAS  PubMed  Google Scholar 

  10. Le Discorde M, Moreau P, Sabatier P, Legeais JM, Carosella ED (2003) Expression of HLA-G in human cornea, an immune-privileged tissue. Hum Immunol 64:1039–1044

    Article  CAS  PubMed  Google Scholar 

  11. Cirulli V et al (2006) The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G. Diabetes 55:1214–1222

    Article  CAS  PubMed  Google Scholar 

  12. Ito T et al (2005) Immunology of the human nail apparatus: the nail matrix is a site of relative immune privilege. J Invest Dermatol 125:1139–1148

    Article  CAS  PubMed  Google Scholar 

  13. Ishitani A, Geraghty DE (1992) Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci USA 89:3947–3951

    Article  CAS  PubMed  Google Scholar 

  14. Kirszenbaum M, Moreau P, Gluckman E, Dausset J, Carosella E (1994) An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc Natl Acad Sci USA 91:4209–4213

    Article  CAS  PubMed  Google Scholar 

  15. Rajagopalan S, Long EO (1999) A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 189:1093–1100

    Article  CAS  PubMed  Google Scholar 

  16. Colonna M, Navarro F, Bellon T, Llano M, Samaridis J, Angman L, Cella M, Lopez-Botet M (1997) A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 186:1809–1818

    Article  CAS  PubMed  Google Scholar 

  17. Colonna M et al (1998) Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 160:3096–3100

    CAS  PubMed  Google Scholar 

  18. Shiroishi M et al (2003) Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci USA 100:8856–8861

    Article  CAS  PubMed  Google Scholar 

  19. LeMaoult J, Caumartin J, Daouya M, Favier B, Le Rond S, Gonzalez A, Carosella ED (2007) Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. Blood 109:2040–2048

    Article  CAS  PubMed  Google Scholar 

  20. Caumartin J, Favier B, Daouya M, Guillard C, Moreau P, Carosella ED, LeMaoult J (2007) Trogocytosis-based generation of suppressive NK cells. EMBO J 26:1423–1433

    Article  CAS  PubMed  Google Scholar 

  21. Rouas-Freiss N, Goncalves RM, Menier C, Dausset J, Carosella ED (1997) Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 94:11520–11525

    Article  CAS  PubMed  Google Scholar 

  22. Carosella ED, Moreau P, Lemaoult J, Rouas-Freiss N (2008) HLA-G: from biology to clinical benefits. Trends Immunol 29:125–132

    Article  CAS  PubMed  Google Scholar 

  23. Rouas-Freiss N, Naji A, Durrbach A, Carosella ED (2007) Tolerogenic functions of human leukocyte antigen G: from pregnancy to organ and cell transplantation. Transplantation 84:S21–S25

    Article  CAS  PubMed  Google Scholar 

  24. Lila N et al (2002) Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 105:1949–1954

    Article  PubMed  Google Scholar 

  25. Lila N, Carpentier A, Amrein C, Khalil-Daher I, Dausset J, Carosella ED (2000) Implication of HLA-G molecule in heart-graft acceptance. Lancet 355:2138

    Article  CAS  PubMed  Google Scholar 

  26. Sheshgiri R, Rao V, Tumiati LC, Xiao R, Prodger JL, Badiwala M, Librach C, Delgado DH (2008) Progesterone induces human leukocyte antigen-g expression in vascular endothelial and smooth muscle cells. Circulation 118:S58–S64

    Article  CAS  PubMed  Google Scholar 

  27. Créput C et al (2003) HLA-G expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation. J Hepatol 39:587–594

    Article  PubMed  Google Scholar 

  28. Creput C, Le Friec G, Bahri R, Amiot L, Charpentier B, Carosella E, Rouas-Freiss N, Durrbach A (2003) Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: possible implications for monitoring patients. Hum Immunol 64:1033–1038

    Article  CAS  PubMed  Google Scholar 

  29. Naji A et al (2007) CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T cell subsets involved in transplant acceptance. Blood 110:3936–3948

    Article  CAS  PubMed  Google Scholar 

  30. Brugiere O et al (2009) Immunohistochemical study of HLA-G expression in lung transplant recipients. Am J Transplant 9:1427–1438

    Article  CAS  PubMed  Google Scholar 

  31. Lila N, Amrein C, Guillemain R, Chevalier P, Fabiani JN, Carpentier A (2007) Soluble human leukocyte antigen-G: a new strategy for monitoring acute and chronic rejections after heart transplantation. J Heart Lung Transplant 26:421–422

    Article  PubMed  Google Scholar 

  32. Luque J et al (2006) sHLA-G levels in the monitoring of immunosuppressive therapy and rejection following heart transplantation. Transpl Immunol 17:70–73

    Article  CAS  PubMed  Google Scholar 

  33. Luque J et al (2006) Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy. Hum Immunol 67:257–263

    Article  CAS  PubMed  Google Scholar 

  34. Qiu J, Terasaki PI, Miller J, Mizutani K, Cai J, Carosella ED (2006) Soluble HLA-G expression and renal graft acceptance. Am J Transplant 6:2152–2156

    Article  CAS  PubMed  Google Scholar 

  35. Rebmann V, Bartsch D, Wunsch A, Mollenbeck P, Golda T, Viebahn R, Grosse-Wilde H (2009) Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation. Hum Immunol 70:995–999

    Article  CAS  PubMed  Google Scholar 

  36. Sheshgiri R, Rao V, Mociornita A, Ross HJ, Delgado DH (2010) Association between HLA-G expression and C4d staining in cardiac transplantation. Transplantation 89:480–481

    Article  PubMed  Google Scholar 

  37. Hviid TV, Hylenius S, Rorbye C, Nielsen LG (2003) HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 55:63–79

    CAS  PubMed  Google Scholar 

  38. O’Brien M, McCarthy T, Jenkins D, Paul P, Dausset J, Carosella ED, Moreau P (2001) Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: possible role of the HLA-G gene in susceptibility to the disease. Cell Mol Life Sci 58:1943–1949

    Article  PubMed  Google Scholar 

  39. Hiby SE, King A, Sharkey A, Loke YW (1999) Molecular studies of trophoblast HLA-G: polymorphism, isoforms, imprinting and expression in preimplantation embryo. Tissue Antigens 53:1–13

    Article  CAS  PubMed  Google Scholar 

  40. Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED, Moreau P (2003) The 14 bp deletion-insertion polymorphism in the 3’ UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 64:1005–1010

    Article  CAS  PubMed  Google Scholar 

  41. Torres MI, Luque J, Lorite P, Isla-Tejera B, Palomeque T, Aumente MD, Arizon J, Pena J (2009) 14-Base pair polymorphism of human leukocyte antigen-G as genetic determinant in heart transplantation and cyclosporine therapy monitoring. Hum Immunol 70:830–835

    Article  CAS  PubMed  Google Scholar 

  42. Tan Z, Shon AM, Ober C (2005) Evidence of balancing selection at the HLA-G promoter region. Hum Mol Genet 14:3619–3628

    Article  CAS  PubMed  Google Scholar 

  43. Hviid TV, Rizzo R, Christiansen OB, Melchiorri L, Lindhard A, Baricordi OR (2004) HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms. Immunogenetics 56:135–141

    Article  CAS  PubMed  Google Scholar 

  44. Yang Y, Geraghty DE, Hunt JS (1995) Cytokine regulation of HLA-G expression in human trophoblast cell lines. J Reprod Immunol 29:179–195

    Article  CAS  PubMed  Google Scholar 

  45. Moreau P, Adrian-Cabestre F, Menier C, Guiard V, Gourand L, Dausset J, Carosella ED, Paul P (1999) IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol 11:803–811

    Article  CAS  PubMed  Google Scholar 

  46. Lefebvre S et al (2001) A specific interferon (IFN)-stimulated response element of the distal HLA-G promoter binds IFN-regulatory factor 1 and mediates enhancement of this nonclassical class I gene by IFN-beta. J Biol Chem 276:6133–6139

    Article  CAS  PubMed  Google Scholar 

  47. Chu W, Gao J, Murphy WJ, Hunt JS (1999) A candidate interferon-gamma activated site (GAS element) in the HLA-G promoter does not bind nuclear proteins. Hum Immunol 60:1113–1118

    Article  CAS  PubMed  Google Scholar 

  48. Chu W, Yang Y, Geraghty DE, Hunt JS (1999) Interferons enhance HLA-G mRNA and protein in transfected mouse fibroblasts. J Reprod Immunol 42:1–15

    Article  CAS  PubMed  Google Scholar 

  49. Cadet P, Rady PL, Tyring SK, Yandell RB, Hughes TK (1995) Interleukin-10 messenger ribonucleic acid in human placenta: implications of a role for interleukin-10 in fetal allograft protection. Am J Obstet Gynecol 173:25–29

    Article  CAS  PubMed  Google Scholar 

  50. Selmani Z et al (2008) Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25high FOXP3+regulatory T cells. Stem Cells 26:212–222

    Article  CAS  PubMed  Google Scholar 

  51. Dunker K, Schlaf G, Bukur J, Altermann WW, Handke D, Seliger B (2008) Expression and regulation of non-classical HLA-G in renal cell carcinoma. Tissue Antigens 72:137–148

    Article  CAS  PubMed  Google Scholar 

  52. Blanco O, Tirado I, Munoz-Fernandez R, Abadia-Molina AC, Garcia-Pacheco JM, Pena J, Olivares EG (2008) Human decidual stromal cells express HLA-G: effects of cytokines and decidualization. Hum Reprod 23:144–152

    Article  CAS  PubMed  Google Scholar 

  53. Sebti Y et al (2003) Soluble HLA-G molecules are increased in lymphoproliferative disorders. Hum Immunol 64:1093–1101

    Article  CAS  PubMed  Google Scholar 

  54. Makris A, Xu B, Yu B, Thornton C, Hennessy A (2006) Placental deficiency of interleukin-10 (IL-10) in preeclampsia and its relationship to an IL10 promoter polymorphism. Placenta 27:445–451

    Article  CAS  PubMed  Google Scholar 

  55. Goldman-Wohl DS, Ariel I, Greenfield C, Hanoch J, Yagel S (2000) HLA-G expression in extravillous trophoblasts is an intrinsic property of cell differentiation: a lesson learned from ectopic pregnancies. Mol Hum Reprod 6:535–540

    Article  CAS  PubMed  Google Scholar 

  56. Spencer JV, Lockridge KM, Barry PA, Lin G, Tsang M, Penfold ME, Schall TJ (2002) Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J Virol 76:1285–1292

    Article  CAS  PubMed  Google Scholar 

  57. Moreau P, Flajollet S, Carosella ED (2009) Non-classical transcriptional regulation of HLA-G: an update. J Cell Mol Med 13:2973–2989

    Article  PubMed  Google Scholar 

  58. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ (1997) Regulation of human placental development by oxygen tension. Science 277:1669–1672

    Article  CAS  PubMed  Google Scholar 

  59. Brahimi-Horn MC, Chiche J, Pouyssegur J (2007) Hypoxia and cancer. J Mol Med 85:1301–1307

    Article  PubMed  Google Scholar 

  60. Mazure NM et al (2004) HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs. Biochem Pharmacol 68:971–980

    Article  CAS  PubMed  Google Scholar 

  61. Chang CC, Ferrone S (2003) HLA-G in melanoma: can the current controversies be solved? Semin Cancer Biol 13:361–369

    Article  CAS  PubMed  Google Scholar 

  62. Mouillot G, Marcou C, Zidi I, Guillard C, Sangrouber D, Carosella ED, Moreau P (2007) Hypoxia modulates HLA-G gene expression in tumor cells. Hum Immunol 68:277–285

    Article  CAS  PubMed  Google Scholar 

  63. Moreau P et al (2001) Glucocorticoid hormones upregulate levels of HLA-G transcripts in trophoblasts. Transplant Proc 33:2277–2280

    Article  CAS  PubMed  Google Scholar 

  64. Sheshgiri R et al (2008) Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients. J Heart Lung Transplant 27:522–527

    Article  PubMed  Google Scholar 

  65. Chavez H, Beaudreuil S, Abbed K, Taoufic Y, Kriaa F, Charpentier B, Durrbach A (2007) Absence of CD4CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28-CD80/86 blockade. Transpl Immunol 17:243–248

    Article  CAS  PubMed  Google Scholar 

  66. Bahri R, Naji A, Menier C, Charpentier B, Carosella ED, Rouas-Freiss N, Durrbach A (2009) Dendritic cells secrete the immunosuppressive HLA-G molecule upon CTLA4-Ig treatment: implication in human renal transplant acceptance. J Immunol 183:7054–7062

    Article  CAS  PubMed  Google Scholar 

  67. Sheshgiri R, Gustafsson F, Sheedy J, Rao V, Ross HJ, Delgado DH (2009) Everolimus but not mycophenolate mofetil therapy is associated with soluble HLA-G expression in heart transplant patients. J Heart Lung Transplant 28:1193–1197

    Article  PubMed  Google Scholar 

  68. Naji A, Durrbach A, Carosella ED, Rouas-Freiss N (2007) Soluble HLA-G and HLA-G1 expressing antigen-presenting cells inhibit T-cell alloproliferation through ILT-2/ILT-4/FasL-mediated pathways. Hum Immunol 68:233–239

    Article  CAS  PubMed  Google Scholar 

  69. Riteau B, Menier C, Khalil-Daher I, Sedlik C, Dausset J, Rouas-Freiss N, Carosella ED (1999) HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol 43:203–211

    Article  CAS  PubMed  Google Scholar 

  70. Lila N, Rouas-Freiss N, Dausset J, Carpentier A, Carosella ED (2001) Soluble HLA-G protein secreted by allo-specific CD4+T cells suppresses the allo-proliferative response: a CD4+T cell regulatory mechanism. Proc Natl Acad Sci USA 98:12150–12155

    Article  CAS  PubMed  Google Scholar 

  71. Riteau B, Rouas-Freiss N, Menier C, Paul P, Dausset J, Carosella ED (2001) HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol 166:5018–5026

    CAS  PubMed  Google Scholar 

  72. Colonna M et al (1998) Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 160:3096–3100

    CAS  PubMed  Google Scholar 

  73. Liang S, Baibakov B, Horuzsko A (2002) HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor. Eur J Immunol 32:2418–2426

    Article  CAS  PubMed  Google Scholar 

  74. Le Gal FA et al (1999) HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol 11:1351–1356

    Article  CAS  PubMed  Google Scholar 

  75. Riteau B, Menier C, Khalil-Daher I, Martinozzi S, Pla M, Dausset J, Carosella ED, Rouas-Freiss N (2001) HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition. Int Immunol 13:193–201

    Article  CAS  PubMed  Google Scholar 

  76. Contini P, Ghio M, Poggi A, Filaci G, Indiveri F, Ferrone S, Puppo F (2003) Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 33:125–134

    Article  CAS  PubMed  Google Scholar 

  77. Fournel S, Aguerre-Girr M, Huc X, Lenfant F, Alam A, Toubert A, Bensussan A, Le Bouteiller P (2000) Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+cells by interacting with CD8. J Immunol 164:6100–6104

    CAS  PubMed  Google Scholar 

  78. Lindemann M, Rebmann V, Ottinger HD, Schmolke K, Kreuzfelder E, Grosse-Wilde H (2004) rhG-CSF effect on mixed lymphocyte cultures and circulating soluble HLA antigen levels in volunteer stem cell donors. Exp Hematol 32:1103–1109

    Article  CAS  PubMed  Google Scholar 

  79. Bahri R et al (2006) Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes. J Immunol 176:1331–1339

    CAS  PubMed  Google Scholar 

  80. Le Rond S, Azema C, Krawice-Radanne I, Durrbach A, Guettier C, Carosella ED, Rouas-Freiss N (2006) Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/regulatory T cells. J Immunol 176:3266–3276

    CAS  PubMed  Google Scholar 

  81. Suarez A, Mozo L, Gutierrez C (2002) Generation of CD4(+)CD45RA(+) effector T cells by stimulation in the presence of cyclic adenosine 5′-monophosphate-elevating agents. J Immunol 169:1159–1167

    CAS  PubMed  Google Scholar 

  82. Wan YY, Flavell RA (2006) The roles for cytokines in the generation and maintenance of regulatory T cells. Immunol Rev 212:114–130

    Article  CAS  PubMed  Google Scholar 

  83. Horuzsko A, Lenfant F, Munn DH, Mellor AL (2001) Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice. Int Immunol 13:385–394

    Article  CAS  PubMed  Google Scholar 

  84. Tsuji H et al (2010) Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes. Circ Res 106:1613–1623

    Article  CAS  PubMed  Google Scholar 

  85. Lo Celso C et al (2009) Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature 457:92–96

    Article  CAS  PubMed  Google Scholar 

  86. Pittenger MF et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147

    Article  CAS  PubMed  Google Scholar 

  87. Deschaseaux F, Pontikoglou C, Sensebe L (2010) Bone regeneration: the stem/progenitor cells point of view. J Cell Mol Med 14:103–115

    Article  CAS  PubMed  Google Scholar 

  88. Deschaseaux F, Sensebe L, Heymann D (2009) Mechanisms of bone repair and regeneration. Trends Mol Med 15:417–429

    Article  CAS  PubMed  Google Scholar 

  89. Kode JA, Mukherjee S, Joglekar MV, Hardikar AA (2009) Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy 11:377–391

    Article  CAS  PubMed  Google Scholar 

  90. Le Blanc K et al (2005) Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 79:1607–1614

    Article  PubMed  Google Scholar 

  91. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY, Muul L, Hofmann T (2002) Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci USA 99:8932–8937

    Article  CAS  PubMed  Google Scholar 

  92. Uccelli A, Moretta L, Pistoia V (2008) Mesenchymal stem cells in health and disease. Nat Rev Immunol 8:726–736

    Article  CAS  PubMed  Google Scholar 

  93. Morandi F et al (2008) Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T-cell responses against viral or tumor-associated antigens. Stem Cells 26:1275–1287

    Article  CAS  PubMed  Google Scholar 

  94. Le Blanc K, Ringden O (2005) Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11:321–334

    Article  CAS  PubMed  Google Scholar 

  95. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, Ringden O (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439–1441

    Article  PubMed  Google Scholar 

  96. Secco M et al (2008) Multipotent stem cells from umbilical cord: cord is richer than blood!. Stem Cells 26:146–150

    Article  CAS  PubMed  Google Scholar 

  97. Yen BL et al (2005) Isolation of multipotent cells from human term placenta. Stem Cells 23:3–9

    Article  CAS  PubMed  Google Scholar 

  98. Ivanova-Todorova E et al (2009) HLA-G expression is up-regulated by progesterone in mesenchymal stem cells. Am J Reprod Immunol 62:25–33

    Article  CAS  PubMed  Google Scholar 

  99. Avanzini MA et al (2009) Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors. Haematologica 94:1649–1660

    Article  CAS  PubMed  Google Scholar 

  100. LeMaoult J, Le Discorde M, Rouas-Freiss N, Moreau P, Menier C, McCluskey J, Carosella ED (2003) Biology and functions of human leukocyte antigen-G in health and sickness. Tissue Antigens 62:273–284

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antoine Durrbach.

Additional information

An erratum to this article can be found at http://dx.doi.org/10.1007/s00018-010-0620-3

Rights and permissions

Reprints and permissions

About this article

Cite this article

Deschaseaux, F., Delgado, D., Pistoia, V. et al. HLA-G in organ transplantation: towards clinical applications. Cell. Mol. Life Sci. 68, 397–404 (2011). https://doi.org/10.1007/s00018-010-0581-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00018-010-0581-6

Keywords

Navigation